CBL — Control Bionics Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$6.23m
- AU$4.99m
- AU$5.91m
- 36
- 64
- 29
- 42
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -2.76 | -4.13 | -7.6 | -11.6 | -10.8 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -1.95 | -0.864 | -3.99 | -6.89 | -4.53 |
Capital Expenditures | -0.036 | -0.302 | -0.053 | -0.148 | -0.458 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Cash from Investing Activities | -0.036 | -0.302 | -0.053 | -0.148 | -0.458 |
Financing Cash Flow Items | — | — | -0.715 | 0 | — |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.933 | 1.79 | 14.9 | -0.087 | 0.706 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -1.04 | 0.63 | 10.9 | -7.12 | -4.28 |